MedPath

Regulation and Mechanism of New Compound Functional Ingredients in Infants

Conditions
Oligosaccharide
Sialic Acid
Interventions
Dietary Supplement: The infants who drank milk powder were given a dietary intervention four months before
Registration Number
NCT05297006
Lead Sponsor
Peking University Third Hospital
Brief Summary

A prospective, multicentre, randomized, double-blind, parallel control study was conducted to analyze the changes in growth, intestinal flora, and immune function of infants with different feeding patterns from postnatal to 1 year of age.

Detailed Description

Breast milk is the most beneficial and safe natural food for the growth and development of infants, but some mothers cannot complete breast feeding.For infants who cannot be breastfed, how to improve the composition of formula milk powder and improve the growth and development of infants is an important issue to be solved urgently in this field.It has been found that new compound functional ingredients oligosaccharides and sialic acid may be beneficial to the healthy growth and development of infants and young children, but the specific mechanism and significance are still unclear due to the lack of systematic research.Known as the "second Brain", the gut is connected to the Brain via the brain-gut-axis.Intestinal microecological status can significantly affect the development of infant nervous system and immune system, and then affect the occurrence of related diseases in adulthood.Oligosaccharides and sialic acid may affect the structure of intestinal microecology, protect the immune function of infants and promote the healthy development of infants.This project is based on the previous studies, using multicenter, prospective, randomized, double-blind, parallel-group trial, discussion of oligosaccharides and sialic acid in infants and young children the intestinal micro ecology and the regulation of immune function and the role mechanism, revealing the oligosaccharides and sialic acid in infants and young children the role of immediate and long-term growth, and the significance of these new type of composite function is added to the dairy ingredients, to research and development more accord with our country new dairy products provide theoretical basis for the healthy growth of infants and young children.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
180
Inclusion Criteria
  1. Healthy infants;
  2. Full-term (gestational age ≥37 weeks);
  3. Birth weight 2500-4500g;
  4. Mothers have no history of diabetes, hypertension, heart disease, and other diseases during pregnancy;
  5. The guardian signed informed consent and voluntarily enrolled into the group and promised to complete systematic follow-up.
Read More
Exclusion Criteria
  1. Hospitalization with cognitive impairment or deformity ≥2 days
  2. History of birth asphyxia (Apgar score < 3)
  3. Severe allergy to milk and serious medical conditions such as intracranial hemorrhage, chronic diarrhea, necrotizing colitis, or acute infection
  4. The guardian refused to enroll or could not complete the system follow-up.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Formula group containing new compound functional ingredientsThe infants who drank milk powder were given a dietary intervention four months beforeOnly use formula milk powder containing oligosaccharides, sialic acid and other ingredients feed the infants for at least 4 months, and then complementary food is added scientifically according to the infant's condition.
Formula group without new compound functional ingredientsThe infants who drank milk powder were given a dietary intervention four months beforeOnly use formula milk powder without oligosaccharides, sialic acid and other ingredients feed the infants for at least 4 months, and then complementary food is added scientifically according to the infant's condition.
Primary Outcome Measures
NameTimeMethod
Growth and development indexes12 months

Baby body head circumference gain

Neurodevelopmental level6 months

The Peabody scale was used to assess the level of neural development of infants at 6 months

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Peking University Third Hospital

🇨🇳

Beijing, Beijing, China

Peking University People's Hospital

🇨🇳

Beijing, Beijing, China

Peking University First Hospital

🇨🇳

Beijing, China

© Copyright 2025. All Rights Reserved by MedPath